Dupilumab treatment in patients with atopic dermatitis: a comparative cohort study between the Netherlands and Japan shows a discrepancy in patient-reported outcome measures.

Linde E M de WijsR F T FujimotoEleni-Rosalina Andrinopoulou Tamar E C Nijsten Dirk-Jan Hijnen Yoko Kataoka

Published in: The British journal of dermatology (2021)

Dupilumab showed significant, comparable and sustained improvement of EASI scores in Japanese and Dutch patients. However, we found striking differences in the effect on PROMs between the countries, with a better outcome in Japanese patients.

Keyphrases

atopic dermatitis
patient reported
patient reported outcomes
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
combination therapy
replacement therapy